| Literature DB >> 29386538 |
Monika Srivastava1, Narsingh R Nirala1, S K Srivastava1,2, Rajiv Prakash3.
Abstract
Label-free and sensitive detection of PSA (Entities:
Mesh:
Substances:
Year: 2018 PMID: 29386538 PMCID: PMC5792442 DOI: 10.1038/s41598-018-19733-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1TEM image of (A) GQDs (B) AuNRs (C) GQDs-AuNRs composite.
Figure 2SEM image of modified electrode with (A) GQDs-AuNRs, (B) Anti-PSA, and (C) Aptamers.
Comparative study of biosensor efficiency.
| Techniques | Aptasensor | Immunosensor | |
|---|---|---|---|
| CV | Sensitivity | 3.7 µA ng mL−1 | 4.6 µA ng mL−1 |
| LOD | 0.14 ng mL−1 | 0.14 ng mL−1 | |
| DPV | Sensitivity | 2.5 µA ng mL−1 | 2.39 µA ng mL−1 |
| LOD | 0.14 ng mL−1 | 0.14 ng mL−1 | |
| EIS | Sensitivity | 35 kΩ ng mL−1 | 25.6 kΩ ng mL−1 |
| LOD | 0.14 ng mL−1 | 0.42 ng mL−1 | |
| In-buffer | Sensitivity | 178 × 103 kΩ ng mL−1 | 140 × 103kΩ ng mL−1 |
| LOD | 0.14 ng mL−1 | 0.42 ng mL−1 | |
Figure 3(A) CV response and (B) EIS data of surface modified screen printed electrode for (a) bare SPE (b) SPE modified with GQD-AuNR (c) with PSA-Aptamer (d) with anti-PSA.
Figure 4Differential pulse voltammogram and corresponding calibration curve of (A,B) PSA-Aptamer and (C,D) Anti-PSA modified electrodes in the presence of different concentration of PSA (0 to 11.06 ng mL−1 as shown here as ‘a’ to ‘j’) in PBS (pH 7.4) with 5 mM [Fe(CN)6]3−/4−.
Figure 5Nyquist plot for impedence measurement and corresponding calibration curve of (A,B) PSA-Aptamer and (C,D) Anti-PSA modified electrodes in presence of different concentration of PSA (0 to 11.06 ng mL−1as shown here as ‘a’ to ‘j’) in PBS (pH 7.4)containing 5 mM [Fe(CN)6]3−/4−.
Figure 6(A) Selectivity with two different concentration of PSA (10 ng mL−1 as PSA1 & 5 ng mL−1 as PSA2) along with different interferents (100 ng mL−1 concentration), (B) Stability and (C) repeatability of aptasensor and immunosensor.
Figure 7Nyquist plot for impedence measurement and corresponding calibration curve of (A,B) PSA-Aptamer and (C,D) Anti-PSA modified electrodes in presence of different concentration of PSA (0 to 11.6 ng mL−1) in human blood serum in PBS (pH 7.4) containing 5 mM [Fe(CN)6]3−/4−.
Figure 8Depiction of GQDs-AuNRs composite preparation.
Figure 9Schematic of Surface modification of bioelectrode (Anti-PSA/Aptamers modified) for PSA detection.